CNTX
CNTX
NASDAQ · Pharmaceuticals

Context Therapeutics Inc

$2.79
-0.39 (-12.26%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +748.7% upside
Low Target $16.27
Average Target $23.68
High Target $31.54
Current Price $2.79
Current
$2.79
Target
$23.68
$16.27 $23.68 avg $31.54
Scenario Analysis
Bear Case
$16.27
483.2%
Low target
Base Case
$23.68
+748.7%
Avg target
Bull Case
$31.54
+1,030.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$22.24
-87.5% from high
52-Week Low
$14.52
+-80.8% from low
Target vs 52W High
$23.68
+6.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%